SCHEMBL3403667

SCHEMBL3403667

CN(C)C1(c2cccs2)CCN(C(=O)CC(NC(=O)Cc2c[nH]c3cc(F)ccc23)c2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.36
LTA4H P09960 1/20 0.35
EPHX2 P34913 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 2/20 0.35
OPRL1 P41146 2/20 0.35
BCHE P06276 2/20 0.35
DRD4 P21917 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
OPRK1 P41145 1/20 0.33
SNCA P37840 1/20 0.33
HTR6 P50406 1/20 0.33
HAT1 O14929 3/20 0.33
EP300 Q09472 3/20 0.33
TACR2 P21452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3401727 0.83 OPRM1 (0.42) NPSR1GAASMN1; SMN2OPRM1OPRL1
SCHEMBL3407505 0.82 NPSR1 (0.39) ACHENPSR1OPRM1OPRL1DRD4
SCHEMBL3407495 0.80 GAA (0.37) NPSR1GAAOPRM1OPRL1SNCA
SCHEMBL3406999 0.79 SIGMAR1 (0.40) ACHEOPRM1OPRL1BCHESIGMAR1
SCHEMBL3405568 0.79 GAA (0.36) NPSR1GAAOPRM1OPRL1SNCA
SCHEMBL3404236 0.79 MAPT (0.43) ACHELTA4HEPHX2GAASMN1; SMN2
SCHEMBL3408786 0.77 OPRM1 (0.35) GAAOPRM1OPRL1OPRK1SNCA
SCHEMBL4103889 0.75 F10 (0.44) SMN1; SMN2OPRM1OPRL1
SCHEMBL4104196 0.74 FAAH (0.39) EPHX2OPRM1OPRL1
SCHEMBL3408808 0.73 NPSR1 (0.42) NPSR1OPRM1OPRL1DRD4SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
CN-102015683-A Substituted indole derivatives GRUENENTHAL GMBH 2011-04-13 CN claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
CN-102015683-A Substituted indole derivatives GRUENENTHAL GMBH 2011-04-13 CN disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 ACHE 97/4885LTA4H 724/4885EPHX2 3081/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 ACHE 97/4885LTA4H 724/4885EPHX2 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.